In one of the largest qui tam False Claims Act (“FCA”) settlements of 2017, pharmaceutical company Mylan Inc. entered into a $465 million dollar settlement. Our Los Angeles based quiRead MorePharmaceutical Company Mylan Settles False Claims Act Whistleblower Lawsuit for $465 Million
